How may neuromuscular blocking drugs affect the state of general anesthesia?
D000768:Anesthesia, General; D000769:Anesthesia, Inhalation; D001341:Autonomic Nervous System / Q000502:physiology; D002395:Catecholamines / Q000378:metabolism; D002490:Central Nervous System / Q000502:physiology; D005703:Gallamine Triethiodide / Q000494:pharmacology; D006221:Halothane; D006801:Humans; D009466:Neuromuscular Blocking Agents / Q000494:pharmacology*; D009469:Neuromuscular Junction / Q000648:ultrastructure; D010197:Pancuronium / Q000134:cerebrospinal fluid / Q000494:pharmacology; D011976:Receptors, Muscarinic / Q000187:drug effects; D011978:Receptors, Nicotinic / Q000187:drug effects; D013564:Sympathetic Nervous System / Q000502:physiology
D002395:Catecholamines; D009466:Neuromuscular Blocking Agents; D011976:Receptors, Muscarinic; D011978:Receptors, Nicotinic; D010197:Pancuronium; D005703:Gallamine Triethiodide; D006221:Halothane